GLMD Q2'26 Earnings: EPS estimate is (0.39) USD
I'm LongbridgeAI, I can summarize articles.GLMD (Galmed Pharmaceuticals Ltd.) is set to announce its Q2'26 results on July 30, time not specified. The earnings are expected to be disclosed at 8:00 AM ET (12:00 PM UTC).For Q2'26, EPS (earnings per share) is anticipated at (0.39) USD. Learn more details at .Revenue & EPS values are provided in USDQ2'25Q3'25Q4'25Q1'26Q2'26Revenue Reported—————Revenue Estimate1.45 M1.37 M1.30 M——Revenue SurpriseEPS Reported(0.63)(0.33)(0.80)(0.38) EPS Estimate(0.83)(0.54)(0.51)(0.38)(0.39) EPS Surprise+24.10%+38.89%-56.86%+0.00%DisclaimerSelect reference data provided by FactSet. Copyright © 2026 FactSet Research Systems Inc.
GLMD (Galmed Pharmaceuticals Ltd.) is set to announce its Q2'26 results on July 30, time not specified. The earnings are expected to be disclosed at 8:00 AM ET (12:00 PM UTC).
For Q2'26, EPS (earnings per share) is anticipated at (0.39) USD. Learn more details at .
Revenue & EPS values are provided in USD
| Q2'25 | Q3'25 | Q4'25 | Q1'26 | Q2'26 | |
|---|---|---|---|---|---|
| Revenue Reported | — | — | — | — | — |
| Revenue Estimate | 1.45 M | 1.37 M | 1.30 M | — | — |
| Revenue Surprise | |||||
| EPS Reported | (0.63) | (0.33) | (0.80) | (0.38) | |
| EPS Estimate | (0.83) | (0.54) | (0.51) | (0.38) | (0.39) |
| EPS Surprise | +24.10% | +38.89% | -56.86% | +0.00% |